Currently, there are 1.65B common shares owned by the public and among those 1.32B shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -7.06% and -12.69% over the past three months. BN shares are trading -6.74% year to date (YTD), with the 12-month market performance up to 29.83% higher. It has a 12-month low price of $38.18 and touched a high of $62.78 over the same period. BN has an average intraday trading volume of 2.18 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.77%, -8.10%, and 3.35% respectively.
Institutional ownership of Brookfield Corporation (NYSE: BN) shares accounts for 56.27% of the company’s 1.65B shares outstanding.
It has a market capitalization of $88.21B and a beta (3y monthly) value of 1.60. The stock’s trailing 12-month PE ratio is 178.01, while the earnings-per-share (ttm) stands at $0.30. The company has a PEG of 11.49 and the debt-to-equity ratio at 5.11. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.34% over the week and 2.52% over the month.
Earnings per share for the fiscal year are expected to decrease by -3.07%, and 20.02% over the next financial year. EPS should grow at an annualized rate of 15.49% over the next five years, compared to -29.74% over the past 5-year period.
Credit Suisse was of a view on March 20, 2023 that the stock is Outperform, while Credit Suisse gave the stock Neutral rating on February 06, 2023, issuing a price target of $42- $41.
